223 related articles for article (PubMed ID: 10761907)
41. Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors.
Groebke Zbinden K; Banner DW; Ackermann J; D'Arcy A; Kirchhofer D; Ji YH; Tschopp TB; Wallbaum S; Weber L
Bioorg Med Chem Lett; 2005 Feb; 15(3):817-22. PubMed ID: 15664864
[TBL] [Abstract][Full Text] [Related]
42. Activation of factor X by factor VIIa complexed with human-mouse tissue factor chimeras requires human exon 3.
Fang CH; Lin TC; Guha A; Nemerson Y; Konigsberg WH
Thromb Haemost; 1996 Sep; 76(3):361-8. PubMed ID: 8883271
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
[TBL] [Abstract][Full Text] [Related]
44. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
Kirchhofer D; Moran P; Chiang N; Kim J; Riederer MA; Eigenbrot C; Kelley RF
Thromb Haemost; 2000 Dec; 84(6):1072-81. PubMed ID: 11154116
[TBL] [Abstract][Full Text] [Related]
45. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
[TBL] [Abstract][Full Text] [Related]
46. Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.
Young WB; Mordenti J; Torkelson S; Shrader WD; Kolesnikov A; Rai R; Liu L; Hu H; Leahy EM; Green MJ; Sprengeler PA; Katz BA; Yu C; Janc JW; Elrod KC; Marzec UM; Hanson SR
Bioorg Med Chem Lett; 2006 Apr; 16(7):2037-41. PubMed ID: 16412633
[TBL] [Abstract][Full Text] [Related]
47. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
[TBL] [Abstract][Full Text] [Related]
48. The factor VIIa/tissue factor complex.
Banner DW
Thromb Haemost; 1997 Jul; 78(1):512-5. PubMed ID: 9198205
[TBL] [Abstract][Full Text] [Related]
49. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
Hathcock JJ; Rusinova E; Andree H; Nemerson Y
Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
[TBL] [Abstract][Full Text] [Related]
50. Macromolecular substrate affinity for free factor VIIa is independent of a buried protease domain N-terminus.
Persson E
Biochem Biophys Res Commun; 2006 Mar; 341(1):28-32. PubMed ID: 16406236
[TBL] [Abstract][Full Text] [Related]
51. Thioester chromogenic substrates for human factor VIIa: substituted isocoumarins are inhibitors of factor VIIa and in vitro anticoagulants.
Kam CM; Vlasuk GP; Smith DE; Arcuri KE; Powers JC
Thromb Haemost; 1990 Aug; 64(1):133-7. PubMed ID: 2274918
[TBL] [Abstract][Full Text] [Related]
52. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors.
Parlow JJ; Kurumbail RG; Stegeman RA; Stevens AM; Stallings WC; South MS
J Med Chem; 2003 Oct; 46(22):4696-701. PubMed ID: 14561089
[TBL] [Abstract][Full Text] [Related]
54. Potent bifunctional anticoagulants: Kunitz domain-tissue factor fusion proteins.
Lee GF; Lazarus RA; Kelley RF
Biochemistry; 1997 May; 36(19):5607-11. PubMed ID: 9153400
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.
Parlow JJ; Stevens AM; Stegeman RA; Stallings WC; Kurumbail RG; South MS
J Med Chem; 2003 Sep; 46(20):4297-312. PubMed ID: 13678408
[TBL] [Abstract][Full Text] [Related]
56. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
57. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
Persson E; Olsen OH
FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
[TBL] [Abstract][Full Text] [Related]
58. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor.
Hamamoto T; Kisiel W
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000
[TBL] [Abstract][Full Text] [Related]
59. The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2.
Kohrt JT; Filipski KJ; Cody WL; Cai C; Dudley DA; Van Huis CA; Willardsen JA; Narasimhan LS; Zhang E; Rapundalo ST; Saiya-Cork K; Leadley RJ; Edmunds JJ
Bioorg Med Chem Lett; 2006 Feb; 16(4):1060-4. PubMed ID: 16289811
[TBL] [Abstract][Full Text] [Related]
60. Crystal structure of the extracellular region of human tissue factor.
Harlos K; Martin DM; O'Brien DP; Jones EY; Stuart DI; Polikarpov I; Miller A; Tuddenham EG; Boys CW
Nature; 1994 Aug; 370(6491):662-6. PubMed ID: 8065454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
